Literature DB >> 18475620

Modulation of nitric oxide synthase activity in macrophages.

P G Jorens1, K E Matthys, H Bult.   

Abstract

L-Arginine is converted to the highly reactive and unstable nitric oxide (NO) and L-citrulline by an enzyme named nitric oxide synthase (NOS). NO decomposes into other nitrogen oxides such as nitrite (NO(2) (-)) and nitrate (NO(2) (-)), and in the presence of superoxide anion to the potent oxidizing agent peroxynitrite (ONOO(-)). Activated rodent macrophages are capable of expressing an inducible form of this enzyme (iNOS) in response to appropriate stimuli, i.e., lipopolysaccharide (LPS) and interferon-gamma (IFNgamma). Other cytokines can modulate the induction of NO biosynthesis in macrophages. NO is a major effector molecule of the anti-microbial and cytotoxic activity of rodent macrophages against certain micro-organisms and tumour cells, respectively. The NO synthesizing pathway has been demonstrated in human monocytes and other cells, but its role in host defence seems to be accessory. A delicate functional balance between microbial stimuli, host-derived cytokines and hormones in the microenvironment regulates iNOS expression. This review will focus mainly on the known and proposed mechanisms of the regulation of iNOS induction, and on agents that can modulate NO release once the active enzyme has been expressed in the macrophage.

Entities:  

Year:  1995        PMID: 18475620      PMCID: PMC2365621          DOI: 10.1155/S0962935195000135

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  237 in total

1.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Authors:  C J Lowenstein; C S Glatt; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor.

Authors:  S J Green; T Y Chen; R M Crawford; C A Nacy; D C Morrison; M S Meltzer
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

3.  Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis.

Authors:  L E Lambert; J F French; J P Whitten; B M Baron; I A McDonald
Journal:  Eur J Pharmacol       Date:  1992-05-27       Impact factor: 4.432

4.  Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.

Authors:  R G Bogle; S Moncada; J D Pearson; G E Mann
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

5.  Serine-protease inhibitors modulate nitric oxide-synthase activity of alveolar macrophages.

Authors:  P G Jorens; F J Van Overeld; H Bult; P A Vermeire; A G Herman
Journal:  Agents Actions       Date:  1992-07

6.  Soybean trypsin inhibitor and beta-amylase induce alveolar macrophages to release nitrogen oxides.

Authors:  P G Jorens; F J Van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

Review 7.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

8.  Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.

Authors:  R Lelchuk; M W Radomski; J F Martin; S Moncada
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

9.  The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.

Authors:  R T Gazzinelli; I P Oswald; S Hieny; S L James; A Sher
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

10.  Calmodulin is a subunit of nitric oxide synthase from macrophages.

Authors:  H J Cho; Q W Xie; J Calaycay; R A Mumford; K M Swiderek; T D Lee; C Nathan
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Nitric oxide: biological role and clinical uses.

Authors:  M S Kannan; S Guiang; D E Johnson
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

2.  Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice.

Authors:  P L Jacob; J A Leite; A K A Alves; Y K S Rodrigues; F M Amorim; P L N Néris; M R Oliveira; S Rodrigues-Mascarenhas
Journal:  Parasitol Res       Date:  2012-10-04       Impact factor: 2.289

3.  Selective and Sensocompatible Electrochemical Nitric Oxide Sensor with a Bilaminar Design.

Authors:  Micah D Brown; Mark H Schoenfisch
Journal:  ACS Sens       Date:  2019-06-20       Impact factor: 7.711

4.  Seasonal immune rhythm of leukocytes in the freshwater snakehead fish, Channa punctatus.

Authors:  Ajay Kumar Bhardwaj; Rakesh Kumar Chandra; Atanu Kumar Pati; Manish Kumar Tripathi
Journal:  J Comp Physiol B       Date:  2022-09-02       Impact factor: 2.230

5.  Extract from Calotropis procera latex activates murine macrophages.

Authors:  Abdel latif Shaker Seddek; Motamed Elsayed Mahmoud; Takahiko Shiina; Haruko Hirayama; Momoe Iwami; Seiji Miyazawa; Hideki Nikami; Tadashi Takewaki; Yasutake Shimizu
Journal:  J Nat Med       Date:  2009-04-28       Impact factor: 2.343

6.  IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.

Authors:  F Jacobs; D Chaussabel; C Truyens; V Leclerq; Y Carlier; M Goldman; B Vray
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

7.  Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.

Authors:  Isaac G Sakala; Christopher S Eickhoff; Azra Blazevic; Phillip Moheno; Richard F Silver; Daniel F Hoft
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

8.  Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages.

Authors:  Rebecca Gupte; Tulip Nandu; W Lee Kraus
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

9.  Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.

Authors:  Lei Xiao; Magdalena Ornatowska; Guiqing Zhao; Hongmei Cao; Rui Yu; Jing Deng; Yongchao Li; Qiong Zhao; Ruxana T Sadikot; John W Christman
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  The contribution of the immune system to parturition.

Authors:  R D Jongh; P Jorens; I Student; R Heylen
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.